The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age

Kidney International

Volumn 91, Issue 5, 2017, Pages 1126-1145

  Sweetwyne, Mariya T ^a   Pippin, Jeffrey W ^a   Eng, Diana G ^a   Hudkins, Kelly L ^b   Chiao, Ying Ann ^b   Campbell, Matthew D ^a   Marcinek, David J ^a   Alpers, Charles E ^b   Szeto, Hazel H ^c   Rabinovitch, Peter S ^b   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

glomerulosclerosis; glomerulus; parietal epithelial cells; podocyte

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA GALACTOSIDASE; CD31 ANTIGEN; COLLAGEN TYPE 4; DESMIN; ELAMIPRETIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P16; SYNAPTOPODIN; ACTIN; ACTIN BINDING PROTEIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; ARGINYL-2,'6'-DIMETHYLTYROSYL-LYSYL-PHENYLALANINAMIDE; MAPK1 PROTEIN, MOUSE; OLIGOPEPTIDE; SYNPO PROTEIN, MOUSE;

ADULT; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DENSITY; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PODOCYTE; RENAL PROTECTION; SENESCENCE; YOUNG ADULT; ANIMAL; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SCLEROSIS; TRANSMISSION ELECTRON MICROSCOPY;

ACTINS; AGING; ANIMALS; COLLAGEN TYPE IV; DESMIN; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; MALE; MICE; MICROFILAMENT PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OLIGOPEPTIDES; PODOCYTES; SCLEROSIS;

EID: 85008472813     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.10.036     Document Type: Article

References (68)

1. 1 United States Renal Data System. 2016 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2016.
2. 2 Ortman JM, Velkoff VA, Hogan H. An aging nation: The older population in the United States. US Census Bureau Publication P25-1140; May 2014. Available at: http://www.census.gov/library/publications/2014/demo/p25-1140.html. Accessed December 21, 2016.
3. 3 Chen, G., Bridenbaugh, E.A., Akintola, A.D., et al. Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction. Am J Physiol Renal Physiol 293 (2007), F1272–F1281.
4. 4 Wang, X., Bonventre, J.V., Parrish, A.R., The aging kidney: increased susceptibility to nephrotoxicity. Int J Mol Sci 15 (2014), 15358–15376.
5. 5 Xue, J.L., Daniels, F., Star, R.A., et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17 (2006), 1135–1142.
6. 6 Denic, A., Glassock, R.J., Rule, A.D., Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis 23 (2016), 19–28.
7. 7 Weinstein, J.R., Anderson, S., The aging kidney: physiological changes. Adv Chronic Kidney Dis 17 (2010), 302–307.
8. 8 Nyengaard, J.R., Bendtsen, T.F., Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 232 (1992), 194–201.
9. 9 Bitzer, M., Wiggins, J., Aging biology in the kidney. Adv Chronic Kidney Dis 23 (2016), 12–18.
10. 10 Jung, K.Y., Dean, D., Jiang, J., et al. Loss of N-cadherin and alpha-catenin in the proximal tubules of aging male Fischer 344 rats. Mech Ageing Dev 125 (2004), 445–453.
11. 11 Wiggins, J.E., Aging in the glomerulus. J Gerontol A Biol Sci Med Sci 67 (2012), 1358–1364.
12. 12 Roeder, S.S., Stefanska, A., Eng, D.G., et al. Changes in glomerular parietal epithelial cells in mouse kidneys with advanced age. Am J Physiol Renal Physiol 309 (2015), F164–F178.
13. 13 Hodgin, J.B., Bitzer, M., Wickman, L., et al. Glomerular aging and focal global glomerulosclerosis: a podometric perspective. J Am Soc Nephrol 26 (2015), 3162–3178.
14. 14 Wiley, C.D., Velarde, M.C., Lecot, P., et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab 23 (2016), 303–314.
15. 15 Correia-Melo, C., Marques, F.D., Anderson, R., et al. Mitochondria are required for pro-ageing features of the senescent phenotype. EMBO J 35 (2016), 724–742.
16. 16 Kruse, S.E., Karunadharma, P.P., Basisty, N., et al. Age modifies respiratory complex I and protein homeostasis in a muscle type-specific manner. Aging Cell 15 (2016), 89–99.
17. 17 Gomes, A.P., Price, N.L., Ling, A.J., et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155 (2013), 1624–1638.
18. 18 Kuka, S., Tatarkova, Z., Racay, P., et al. Effect of aging on formation of reactive oxygen species by mitochondria of rat heart. Gen Physiol Biophys 32 (2013), 415–420.
19. 19 Daum, B., Walter, A., Horst, A., et al. Age-dependent dissociation of ATP synthase dimers and loss of inner-membrane cristae in mitochondria. Proc Natl Acad Sci U S A 110 (2013), 15301–15306.
20. 20 Petrosillo, G., Matera, M., Moro, N., et al. Mitochondrial complex I dysfunction in rat heart with aging: critical role of reactive oxygen species and cardiolipin. Free Radic Biol Med 46 (2009), 88–94.
21. 21 Szeto, H.H., First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 171 (2014), 2029–2050.
22. 22 Birk, A.V., Liu, S., Soong, Y., et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol 24 (2013), 1250–1261.
23. 23 Eirin, A., Ebrahimi, B., Kwon, S.H., et al. Restoration of mitochondrial cardiolipin attenuates cardiac damage in swine renovascular hypertension. J Am Heart Assoc, 5, 2016, e003118.
24. 24 Sabbah, H.N., Gupta, R.C., Kohli, S., et al. Chronic therapy with elamipretide (MTP-131), a novel mitochondria-targeting peptide, improves left ventricular and mitochondrial function in dogs with advanced heart failure. Circ Heart Fail, 9, 2016, e002206.
25. 25 Szeto, H.H., Liu, S., Soong, Y., et al. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 22 (2011), 1041–1052.
26. 26 Szeto, H.H., Liu, S., Soong, Y., et al. Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury. Kidney Int 90 (2016), 997–1011.
27. 27 Sesso, A., Belizario, J.E., Marques, M.M., et al. Mitochondrial swelling and incipient outer membrane rupture in preapoptotic and apoptotic cells. Anat Rec (Hoboken) 295 (2012), 1647–1659.
28. 28 Dai, D.F., Chiao, Y.A., Marcinek, D.J., et al. Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan, 3, 2014, 6.
29. 29 Daiber, A., Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta 1797 (2010), 897–906.
30. 30 Adesina, S.E., Kang, B.Y., Bijli, K.M., et al. Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension. Free Radic Biol Med 87 (2015), 36–47.
31. 31 Bijli, K.M., Kleinhenz, J.M., Murphy, T.C., et al. Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation. Free Radic Biol Med 80 (2015), 111–120.
32. 32 Gomes, P., Simao, S., Silva, E., et al. Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure. Oxid Med Cell Longev 2 (2009), 138–145.
33. 33 Thallas-Bonke, V., Jha, J.C., Gray, S.P., et al. Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy. Physiol Rep, 2, 2014, e12192.
34. 34 Matsushima, S., Kuroda, J., Ago, T., et al. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res 112 (2013), 651–663.
35. 35 Kuroda, J., Nakagawa, K., Yamasaki, T., et al. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10 (2005), 1139–1151.
36. 36 Block, K., Gorin, Y., Abboud, H.E., Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A 106 (2009), 14385–14390.
37. 37 Sciarretta, S., Zhai, P., Shao, D., et al. Activation of NADPH oxidase 4 in the endoplasmic reticulum promotes cardiomyocyte autophagy and survival during energy stress through the protein kinase RNA-activated-like endoplasmic reticulum kinase/eukaryotic initiation factor 2α/activating transcription factor 4 pathway. Circ Res 113 (2013), 1253–1264.
38. 38 Hamilton, M.L., Van Remmen, H., Drake, J.A., et al. Does oxidative damage to DNA increase with age?. Proc Natl Acad Sci U S A 98 (2001), 10469–10474.
39. 39 Kume, S., Uzu, T., Horiike, K., et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest 120 (2010), 1043–1055.
40. 40 Rodriguez-Iturbe, B., Sepassi, L., Quiroz, Y., et al. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol (1985) 102 (2007), 255–260.
41. 41 Eng, D.G., Sunseri, M.W., Kaverina, N.V., et al. Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int 88 (2015), 999–1012.
42. 42 Okamoto, T., Sasaki, S., Yamazaki, T., et al. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy. Nephron Exp Nephrol 124 (2013), 11–18.
43. 43 Pippin, J.W., Glenn, S.T., Krofft, R.D., et al. Cells of renin lineage take on a podocyte phenotype in aging nephropathy. Am J Physiol Renal Physiol 306 (2014), F1198–F1209.
44. 44 Venkatareddy, M., Wang, S., Yang, Y., et al. Estimating podocyte number and density using a single histologic section. J Am Soc Nephrol 25 (2014), 1118–1129.
45. 45 Asanuma, K., Kim, K., Oh, J., et al. Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest 115 (2005), 1188–1198.
46. 46 Herrmann, A., Tozzo, E., Funk, J., Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model. Exp Toxicol Pathol 64 (2012), 45–49.
47. 47 Maruyama, M., Sugiyama, H., Sada, K., et al. Desmin as a marker of proteinuria in early stages of membranous nephropathy in elderly patients. Clin Nephrol 68 (2007), 73–80.
48. 48 Wiggins, J.E., Goyal, M., Sanden, S.K., et al. Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 16 (2005), 2953–2966.
49. 49 Siegel, M.P., Kruse, S.E., Percival, J.M., et al. Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice. Aging Cell 12 (2013), 763–771.
50. 50 Yang, L., Zhao, K., Calingasan, N.Y., et al. Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Antioxid Redox Signal 11 (2009), 2095–2104.
51. 51 Wu, J., Li, H., Sun, X., et al. A mitochondrion-targeted antioxidant ameliorates isoflurane-induced cognitive deficits in aging mice. PLoS One, 10, 2015, e0138256.
52. 52 Manczak, M., Mao, P., Calkins, M.J., et al. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 20 Suppl 2 (2010), S609–S631.
53. 53 Szeto, H.H., Liu, S., Soong, Y., Birk, A.V., Improving mitochondrial bioenergetics under ischemic conditions increases warm ischemia tolerance in the kidney. Am J Physiol Renal Physiol 308 (2015), F11–F21.
54. 54 Dai, D.F., Hsieh, E.J., Chen, T., et al. Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides. Circ Heart Fail 6 (2013), 1067–1076.
55. 55 Brown, D.A., Hale, S.L., Baines, C.P., et al. Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia. J Cardiovasc Pharmacol Ther 19 (2014), 121–132.
56. 56 Eirin, A., Williams, B.J., Ebrahimi, B., et al. Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension. J Hypertens 32 (2014), 154–165.
57. 57 Geifman, N., Rubin, E., The mouse age phenome knowledgebase and disease-specific inter-species age mapping. PLoS One, 8, 2013, e81114.
58. 58 Wiggins, J., Podocytes and glomerular function with aging. Semin Nephrol 29 (2009), 587–593.
59. 59 Hu, T., Ramachandrarao, S.P., Siva, S., et al. Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells. Am J Physiol Renal Physiol 289 (2005), F816–F825.
60. 60 Jha, J.C., Gray, S.P., Barit, D., et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase Nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol 25 (2014), 1237–1254.
61. 61 Eid AA, Ford BM, Bhandary B, et al. Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes. 62:2935–2947.
62. 62 Hou, Y., Li, S., Wu, M., et al. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy. Am J Physiol Renal Physiol 310 (2016), F547–F559.
63. 63 Baker, D.J., Childs, B.G., Durik, M., et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530 (2016), 184–189.
64. 64 Bondi, C.D., Manickam, N., Lee, D.Y., et al. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21 (2010), 93–102.
65. 65 Chen, J., Chen, J.K., Harris, R.C., Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway. Mol Cell Biol 32 (2012), 981–991.
66. 66 van Deursen, J.M., The role of senescent cells in ageing. Nature 509 (2014), 439–446.
67. 67 Ohse, T., Vaughan, M.R., Kopp, J.B., et al. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am J Physiol Renal Physiol 298 (2010), F702–F711.
68. 68 Ohse, T., Chang, A.M., Pippin, J.W., et al. A new function for parietal epithelial cells: a second glomerular barrier. Am J Physiol Renal Physiol 297 (2009), F1566–F1574.